Predictors of Outcome in Clinically Diagnosed Viral Encephalitis Patients: A 5-Year Prospective Study

Table 1

Demographics and clinical presentation of viral encephalitis in our cohort.

Variables		All ()	Good outcome ()	Poor outcome ()	value
Sex	Male	113	80	33	0.514
	Female	103	77	26
Age (years)		43 (26, 58)	42 (25, 55)	52 (35, 66)	0.001
Duration of symptoms before hospitalization (days)		5 (2, 8)	5 (2, 9)	5 (3, 7)	0.873
NICU admission	No	143	115	28	<0.001
	Yes	73	42	31
Total length of stay in NICU (days)		0 (0, 3)	0 (0, 2)	2 (0, 8)	<0.001
Total length of hospital stay (days)		13 (9, 18)	12 (8, 16)	17 (13, 23)	<0.001
Precursor infection	No	115	81	34	0.428
	Yes	101	76	25
Mental and behavior disorder	No	70	58	12	0.020
	Yes	146	99	47
GCS		14 (12, 15)	14 (14, 15)	10 (8, 12)	<0.001
Coma	No	200	155	45	<0.001
	Yes	16	2	14
Nuchal rigidity	No	159	117	42	0.620
	Yes	57	40	17
Focal neurological deficits	No	193	150	43	<0.001
	Yes	23	7	16
Status epilepticus	No	206	155	51	<0.001
	Yes	10	2	8
Seizures	No	173	133	40	0.006
	Yes	43	24	19
Headache	No	114	70	44	<0.001
	Yes	102	87	15
Nausea/vomiting	No	174	123	51	0.180
	Yes	42	34	8
Fever	No	128	94	34	0.765
	Yes	88	63	25
Temperature (°C)		37.1 (36.6, 38.5)	37 (36.6, 38.5)	37.2 (36.6, 38.6)	0.395
Mechanical ventilation	No	205	155	50	<0.001
	Yes	11	2	9
Infection complication	No	174	140	34	<0.001
	Yes	42	17	25
Steroid treatment	No	76	58	18	0.378
	Yes	140	99	41
Antiviral treatment	No	6	5	1	0.897
	Yes	210	152	58